Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy

Molecular Neurobiology

Volumn 47, Issue 3, 2013, Pages 1081-1092

  Gonçalves, Susana ^a   Outeiro, Tiago Fleming ^a,b,c  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alpha synuclein; Intracellular dynamics; Parkinson's disease; Photoactivation

Indexed keywords

ALPHA SYNUCLEIN; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 70; G PROTEIN COUPLED RECEPTOR KINASE 5; PHOSPHOSERINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CELL INCLUSION; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MICROSCOPY; MOUSE; MUTATION; NONHUMAN; PHOTOACTIVATION; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; CELL FRACTIONATION; CELL SURVIVAL; CHEMISTRY; GENETICS; LIGHT; METABOLISM; METHODOLOGY; PARKINSON DISEASE; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT;

ALPHA-SYNUCLEIN; CELL NUCLEUS; CELL SURVIVAL; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GREEN FLUORESCENT PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIGHT; MICROSCOPY; MUTATION; PARKINSON DISEASE; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS;

EID: 84887273441     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8406-x     Document Type: Article

References (53)

1. Spillantini MG, Schmidt ML, Lee V.M., Trojanowski JQ, Jakes R, Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388 (6645):839-840. doi:10.1038/42166
2. Schneider BL, Seehus CR, Capowski E.E., Aebischer P., Zhang SC, Svendsen C.N. (2007) Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. Hum Mol Genet 16(6):651-666
3. Crews L, Mizuno H, Desplats P., Rockenstein E, Adame A, Patrick C., Winner B, Winkler J, Masliah E (2008) Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice. J Neurosci 28(16):4250-4260. doi:10.1523/JNEUROSCI.0066-08.2008
4. Klucken J, Outeiro TF, Nguyen P, McLean P.J., Hyman B.T. (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J 20(12):2050-2057. doi:10.1096/fj.05-5422com
5. Fortin DL, Troyer MD, Nakamura K, Kubo S., Anthony MD, Edwards R.H. (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 24(30):6715-6723. doi:10.1523/JNEUROSCI.1594-04.2004
6. Vivacqua G, Casini A, Vaccaro R., Fornai F, Yu S, D'Este L (2011) Different sub-cellular localization of alpha-synuclein in the C57BL \6J mouse's central nervous system by two novel monoclonal antibodies. J Chem Neuroanat 41(2):97-110. doi:10.1016/j.jchemneu.2010.12.003
7. Goers J, Manning-Bog AB, McCormack A.L., Millett IS, Doniach S, Di Monte DA, Uversky VN, Fink AL (2003) Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42(28):8465-8471. doi:10.1021/bi0341152
8. Unni VK, Weissman TA, Rockenstein E, Masliah E., McLean PJ, Hyman B.T. (2010) In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS One 5(5):e10589. doi:10.1371/journal.pone.0010589
9. Singleton AB, Farrer M, Johnson J., Singleton A, Hague S, Kachergus J., Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302(5646):841
10. Polymeropoulos MH, Lavedan C, Leroy E., Ide SE, Dehejia A, Dutra A, Pike B., Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (5321):2045-2047
11. Kruger R, Kuhn W, Muller T., Woitalla D, Graeber M, Kosel S., Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18(2):106-108
12. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E., Ros R, Ampuero I, Vidal L., Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164-173
13. Ulmer TS, Bax A. (2005) Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J Biol Chem 280(52):43179-43187. doi:10.1074/jbc.M507624200
14. Bodner CR, Maltsev AS, Dobson C.M., Bax A. (2010) Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy. Biochemistry 49(5):862-871. doi:10.1021/bi901723p
15. Fujiwara H, Hasegawa M, Dohmae N., Kawashima A, Masliah E, Goldberg M.S., Shen J., Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160-164
16. Anderson JP, Walker DE, Goldstein J.M., de Laat R, Banducci K, Caccavello R.J., Barbour R., Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281(40):29739-29752. doi:10.1074/jbc.M600933200
17. Pronin AN, Morris AJ, Surguchov A, Benovic J.L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J Biol Chem 275(34):26515-26522
18. Inglis KJ, Chereau D, Brigham E.F., Chiou SS, Schobel S, Frigon NL, Yu M, Caccavello R.J., Nelson S., Motter R, Wright S, Chian D, Santiago P, Soriano F, Ramos C, Powell K, Goldstein JM, Babcock M, Yednock T, Bard F, Basi GS, Sham H, Chilcote TJ, McConlogue L, Griswold-Prenner I, Anderson JP (2009) Pololike kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J Biol Chem 284(5):2598-2602
19. Lou H, Montoya SE, Alerte T.N., Wang J., Wu J, Peng X, Hong C.S., Friedrich EE, Mader SA, Pedersen CJ, Marcus BS, McCormack AL, Di Monte DA, Daubner SC, Perez RG (2010) Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J Biol Chem 285(23):17648-17661. doi:10.1074/jbc.M110.100867
20. Auluck PK, Chan HY, Trojanowski J.Q., Lee VM, Bonini N.M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295 (5556):865-868. doi:10.1126/science.1067389
21. Flower TR, Chesnokova LS, Froelich C.A., Dixon C., Witt S.N. (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 351(5):1081-1100. doi:10.1016/j.jmb.2005.06.060
22. Klucken J, Shin Y, Masliah E., Hyman BT, McLean P.J. (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279(24):25497-25502. doi:10.1074/jbc.M400255200
23. Dedmon MM, Christodoulou J, Wilson M.R., Dobson C.M. (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280(15):14733-14740. doi:10.1074/jbc. M413024200
24. Roy S, Yang G, Tang Y., Scott D.A. (2012) A simple photoactivation and image analysis module for visualizing and analyzing axonal transport with high temporal resolution. Nat Protoc 7(1):62-68. doi:10.1038/nprot.2011.428
25. Lippincott-Schwartz J., Altan-Bonnet N, Patterson G.H. (2003) Photobleaching and photoactivation: following protein dynamics in living cells. Nat Cell Biol Suppl: S7-14
26. Patterson GH, Lippincott-Schwartz J (2002) A photoactivatable GFP for selective photolabeling of proteins and cells. Science 297 (5588):1873-1877
27. Vamvaca K, Volles MJ, Lansbury PT Jr (2009) The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. J Mol Biol 389(2):413-424. doi:10.1016/j.jmb.2009.03.021
28. Yang ML, Hasadsri L, Woods W.S., George J.M. (2010) Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons. Mol Neurodegener 5(1):9. doi:10.1186/1750-1326-5-9
29. Specht CG, Tigaret CM, Rast G.F., Thalhammer A., Rudhard Y, Schoepfer R. (2005) Subcellular localisation of recombinant alpha-and gamma-synuclein. Mol Cell Neurosci 28(2):326-334. doi:10.1016/j.mcn.2004.09.017
30. Kontopoulos E, Parvin JD, Feany M.B. (2006) Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotox-icity. Hum Mol Genet 15(20):3012-3023
31. Siddiqui A, Chinta SJ, Mallajosyula J.K., Rajagopolan S., Hanson I, Rane A, Andersen J.K. (2012) Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease. Free Radic Biol Med. doi:10.1016/j.freeradbiomed.2012.05.024
32. Weinreb PH, Zhen W, Poon A.W., Conway KA, Lansbury PT Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35(43):13709-13715. doi:10.1021/bi961799n
33. Bartels T, Choi JG, Selkoe D.J. (2011) Alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107-110. doi:10.1038/nature10324
34. Wang W, Perovic I, Chittuluru J., Kaganovich A, Nguyen LT, Liao J, Auclair J.R., Johnson D., Landeru A, Simorellis AK, Ju S, Cookson MR, Asturias FJ, Agar JN, Webb BN, Kang C, Ringe D, Petsko GA, Pochapsky TC, Hoang QQ (2011) A soluble alpha-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci U S A 108(43):17797-17802. doi:10.1073/pnas.1113260108
35. Zhu M, Fink A.L. (2003) Lipid binding inhibits alpha-synuclein fibril formation. J Biol Chem 278(19):16873-16877. doi:10.1074/jbc.M210136200
36. Chandra S, Chen X, Rizo J., Jahn R, Sudhof T.C. (2003) A broken alpha-helix in folded alpha-synuclein. J Biol Chem 278(17):15313-15318. doi:10.1074/jbc.M213128200
37. Perrin RJ, Woods WS, Clayton D.F., George J.M. (2000) Interaction of human alpha-synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem 275(44):34393-34398. doi:10.1074/jbc.M004851200
38. Ulmer TS, Bax A, Cole N.B., Nussbaum R.L. (2005) Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem 280(10):9595-9603. doi:10.1074/jbc.M411805200
39. Sousa VL, Bellani S, Giannandrea M., Yousuf M, Valtorta F, Meldolesi J., Chieregatti E. (2009) {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Mol Biol Cell 20(16):3725-3739. doi:10.1091/mbc.E08-03-0302
40. Lashuel HA, Petre BM, Wall J, Simon M., Nowak RJ, Walz T, Lansbury PT Jr (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322(5):1089-1102
41. Oueslati A, Paleologou KE, Schneider B.L., Aebischer P., Lashuel H.A. (2012) Mimicking phosphorylation at serine 87 inhibits the aggregation of human alpha-synuclein and protects against its toxicity in a rat model of Parkinson's disease. J Neurosci 32(5):1536-1544. doi:10.1523/JNEUROSCI.3784-11.2012
42. Hejjaoui M, Butterfield S, Fauvet B., Vercruysse F, Cui J, Dikiy I., Prudent M, Olschewski D, Zhang Y, Eliezer D, Lashuel HA (2012) Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: alpha-synuclein phosphor-ylation at tyrosine 125. J Am Chem Soc 134(11):5196-5210. doi:10.1021/ja210866j
43. Okochi M, Walter J, Koyama A., Nakajo S, Baba M, Iwatsubo T., Meijer L, Kahle PJ, Haass C (2000) Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem 275(1):390-397
44. Chen L, Feany M.B. (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8(5):657-663
45. Mbefo MK, Paleologou KE, Boucharaba A, Oueslati A., Schell H, Fournier M, Olschewski D., Yin G, Zweckstetter M, Masliah E, Kahle PJ, Hirling H, Lashuel HA (2010) Phosphorylation of syn-ucleins by members of the Polo-like kinase family. J Biol Chem 285(4):2807-2822. doi:10.1074/jbc.M109.081950
46. Fiske M, Valtierra S, Solvang K., Zorniak M, White M, Herrera S., Konnikova A, Brezinsky R, Debburman S (2011) Contribution of alanine-76 and serine phosphorylation in alpha-synuclein membrane association and aggregation in yeasts. Park Dis 2011: 392180. doi:10.4061/2011/392180
47. Witt SN (2010) Hsp70 molecular chaperones and Parkinson's disease. Biopolymers 93(3):218-228. doi:10.1002/bip.21302
48. Zhou Y, Gu G, Goodlett D.R., Zhang T., Pan C, Montine TJ, Montine K.S., Aebersold RH, Zhang J (2004) Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279(37):39155-39164. doi:10.1074/jbc. M405456200
49. Murray IV, Giasson BI, Quinn S.M., Koppaka V., Axelsen PH, Ischiropoulos H, Trojanowski JQ, Lee V.M. (2003) Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42(28):8530-8540. doi:10.1021/bi027363r
50. Lee JC, Langen R, Hummel P.A., Gray HB, Winkler J.R. (2004) Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease. Proc Natl Acad Sci U S A 101(47): 16466-16471
51. Outeiro TF, Putcha P, Tetzlaff J.E., Spoelgen R., Koker M, Carvalho F, Hyman B.T., McLean P.J. (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 3(4):e1867. doi:10.1371/journal.pone.0001867
52. McLean PJ, Kawamata H, Hyman B.T. (2001) Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104(3):901-912
53. Outeiro TF, Klucken J, Bercury K., Tetzlaff J, Putcha P, Oliveira L.M., Quintas A., McLean PJ, Hyman BT (2009) Dopamine-induced conformational changes in alpha-synuclein. PLoS One 4(9):e6906. doi:10.1371/journal.pone.0006906